1. Home
  2. BAND vs AVXL Comparison

BAND vs AVXL Comparison

Compare BAND & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bandwidth Inc.

BAND

Bandwidth Inc.

HOLD

Current Price

$14.54

Market Cap

463.9M

Sector

Technology

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$5.25

Market Cap

397.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAND
AVXL
Founded
2000
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
463.9M
397.6M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BAND
AVXL
Price
$14.54
$5.25
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$20.67
$22.00
AVG Volume (30 Days)
187.1K
1.8M
Earning Date
02-19-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$756,118,000.00
N/A
Revenue This Year
$2.82
N/A
Revenue Next Year
$15.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.42
N/A
52 Week Low
$11.33
$2.86
52 Week High
$19.88
$13.99

Technical Indicators

Market Signals
Indicator
BAND
AVXL
Relative Strength Index (RSI) 53.38 70.21
Support Level $13.10 $4.67
Resistance Level $14.41 $5.36
Average True Range (ATR) 0.52 0.32
MACD -0.01 0.16
Stochastic Oscillator 70.59 93.29

Price Performance

Historical Comparison
BAND
AVXL

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: